S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Adaptive Biotechnologies (ADPT) Earnings Date, Estimates & Call Transcripts

$2.34
-0.10 (-4.11%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 7
After Market Closes
Confirmed
Actual EPS
(Feb. 14)
-$0.30 Beat By $0.02
Consensus EPS
(Feb. 14)
-$0.32
Skip Charts & View Estimated and Actual Earnings Data

ADPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Adaptive Biotechnologies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.32)($0.32)($0.32) 
Q2 20241($0.33)($0.33)($0.33) 
Q3 20241($0.32)($0.32)($0.32) 
Q4 20241($0.31)($0.31)($0.31) 
FY 20244($1.28)($1.28)($1.28) 
Q1 20251($0.34)($0.34)($0.34) 
Q2 20251($0.33)($0.33)($0.33) 
Q3 20251($0.32)($0.32)($0.32) 
Q4 20251($0.30)($0.30)($0.30) 
FY 20254($1.29)($1.29) ($1.29)

ADPT Earnings Date and Information

Adaptive Biotechnologies last announced its earnings data on February 14th, 2024. The reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of ($0.32) by $0.02. The business earned $45.78 million during the quarter, compared to analyst estimates of $50.15 million. Adaptive Biotechnologies has generated ($1.56) earnings per share over the last year (($1.56) diluted earnings per share). Earnings for Adaptive Biotechnologies are expected to grow in the coming year, from ($1.31) to ($1.06) per share. Adaptive Biotechnologies has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. Adaptive Biotechnologies will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Adaptive Biotechnologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Confirmed)
-------  
2/14/2024Q4 2023($0.32)($0.30)+$0.02($0.12)$50.15 million$45.78 million
11/9/2023Q3 2023($0.32)($0.35)($0.03)($0.35)$43.26 million$37.92 million
8/2/2023Q2 2023($0.33)($0.33)-($0.33)$44.87 million$48.93 million    
5/3/2023Q1 2023($0.34)($0.40)($0.06)($0.40)$36.81 million$37.65 million    
2/14/2023Q4 2022($0.37)($0.28)+$0.09($0.28)$55.25 million$55.20 million    
11/3/2022Q3 2022($0.37)($0.32)+$0.05($0.32)$48.41 million$47.80 million    
8/3/2022Q2 2022($0.40)($0.37)+$0.03($0.37)$43.30 million$43.66 million    
5/4/2022Q1 2022($0.45)($0.44)+$0.01($0.44)$37.71 million$38.62 million    
2/15/2022Q4 2021($0.43)($0.43)-($0.43)$36.08 million$37.93 million    
11/2/2021Q3 2021($0.42)($0.40)+$0.02($0.40)$37.60 million$39.47 million    
8/3/2021Q2 2021($0.43)($0.35)+$0.08($0.35)$31.12 million$38.50 million    
5/4/2021Q1 2021($0.41)($0.29)+$0.12($0.29)$28.53 million$38.44 million  

Adaptive Biotechnologies Earnings - Frequently Asked Questions

When is Adaptive Biotechnologies's earnings date?

Adaptive Biotechnologies has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on ADPT's earnings history.

Did Adaptive Biotechnologies beat their earnings estimates last quarter?

In the previous quarter, Adaptive Biotechnologies (NASDAQ:ADPT) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.32) by $0.02. Learn more on analysts' earnings estimate vs. ADPT's actual earnings.

How much revenue does Adaptive Biotechnologies generate each year?

Adaptive Biotechnologies (NASDAQ:ADPT) has a recorded annual revenue of $170.28 million.

How much profit does Adaptive Biotechnologies generate each year?

Adaptive Biotechnologies (NASDAQ:ADPT) has a recorded net income of -$225.25 million. ADPT has generated -$1.56 earnings per share over the last four quarters.

What is Adaptive Biotechnologies's EPS forecast for next year?

Adaptive Biotechnologies's earnings are expected to grow from ($1.31) per share to ($1.06) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ADPT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners